N/A
Completed N=29
Exendin-9,39 and Satiety After Bariatric Surgery
Source: ClinicalTrials.gov NCT02779075 ↗Enrolled (actual)
29
Serious AEs
0.0%
Results posted
May 2020
Primary outcomePrimary: Caloric Intake — 531; 465; 444; 494 calories
Summary
The overall aim of the application is to determine the contribution of the elevated incretin hormone concentrations seen after certain types of bariatric surgery to the regulation of food intake and satiety.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Caloric Intake |
531; 465; 444; 494 | — |
| SECONDARY Gastrointestinal Transit Measured Using Scintigraphy |
63; 48; 100; 141 | — |
Eligibility Criteria
Inclusion Criteria
- Undergone either sleeve gastrectomy or Roux-en-Y Gastric Bypass surgery within prior 2 years
- Healthy, with no active systemic illness
Exclusion Criteria
- Pregnancy
- Functional or organic bowel symptoms
- Systemic illness
- Diabetes
- Bariatric surgery > 2 years
Data sourced from ClinicalTrials.gov (NCT02779075). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.